Cheryl Zimberlin is fund manager at Oncode Bridge Fund, looking to build early stage therapeutic companies. She has deep expertise in funding and building biotech ventures, globally. Prior to joining Oncode she was investment director at M Ventures,  the corporate Venture Capital arm of Merck KgAA, Darmstadt, Germany. She has a PhD oncology background.